BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23704193)

  • 1. Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer.
    Sorbye H; Cvancarova M; Qvortrup C; Pfeiffer P; Glimelius B
    Ann Oncol; 2013 Sep; 24(9):2354-60. PubMed ID: 23704193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.
    Benitez Majano S; Di Girolamo C; Rachet B; Maringe C; Guren MG; Glimelius B; Iversen LH; Schnell EA; Lundqvist K; Christensen J; Morris M; Coleman MP; Walters S
    Lancet Oncol; 2019 Jan; 20(1):74-87. PubMed ID: 30545752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.
    Golan T; Urban D; Berger R; Lawrence YR
    Cancer; 2013 Aug; 119(16):3084-91. PubMed ID: 23720150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004.
    Meulenbeld HJ; van Steenbergen LN; Janssen-Heijnen ML; Lemmens VE; Creemers GJ
    Ann Oncol; 2008 Sep; 19(9):1600-4. PubMed ID: 18467312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in survival of metastatic colorectal cancer: are the benefits of clinical trials reproduced in population-based studies?
    Mitry E; Rollot F; Jooste V; Guiu B; Lepage C; Ghiringhelli F; Faivre J; Bouvier AM
    Eur J Cancer; 2013 Sep; 49(13):2919-25. PubMed ID: 23642328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.
    Kumar R; Jain K; Beeke C; Price TJ; Townsend AR; Padbury R; Roder D; Young GP; Richards A; Karapetis CS
    Cancer; 2013 Feb; 119(4):722-8. PubMed ID: 22990939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time trends of short-term mortality for octogenarians undergoing a colorectal resection in North Europe.
    Claassen YHM; Bastiaannet E; van Eycken E; Van Damme N; Martling A; Johansson R; Iversen LH; Ingeholm P; Lemmens VEPP; Liefers GJ; Holman FA; Dekker JWT; Portielje JEA; Rutten HJ; van de Velde CJH
    Eur J Surg Oncol; 2019 Aug; 45(8):1396-1402. PubMed ID: 31003722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.
    Maringe C; Walters S; Rachet B; Butler J; Fields T; Finan P; Maxwell R; Nedrebø B; Påhlman L; Sjövall A; Spigelman A; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris E; McGahan CE; Tracey E; Turner D; Richards MA; Coleman MP;
    Acta Oncol; 2013 Jun; 52(5):919-32. PubMed ID: 23581611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and colorectal cancer with focus on the elderly: trends in relative survival and initial treatment from a Danish population-based study.
    Iversen LH; Pedersen L; Riis A; Friis S; Laurberg S; Sørensen HT
    Dis Colon Rectum; 2005 Sep; 48(9):1755-63. PubMed ID: 15981072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
    Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
    Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and Norway.
    Breugom AJ; Bastiaannet E; Guren MG; Kørner H; Boelens PG; Dekker FW; Kapiteijn E; Gelderblom H; Larsen IK; Liefers GJ; van de Velde CJH
    Eur J Surg Oncol; 2020 Jun; 46(6):1167-1173. PubMed ID: 32151531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry.
    Tomita Y; Karapetis CS; Ullah S; Townsend AR; Roder D; Beeke C; Roy AC; Padbury R; Price TJ
    Acta Oncol; 2016; 55(4):480-5. PubMed ID: 26878155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer.
    Ferrarotto R; Machado K; Mak MP; Shah N; Takahashi TK; Costa FP; Overman MJ; Kopetz S; Hoff PM
    Eur J Cancer; 2012 Apr; 48(6):820-6. PubMed ID: 22330318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness.
    Bencsikova B; Budinska E; Selingerova I; Pilatova K; Fedorova L; Greplova K; Nenutil R; Valik D; Obermannova R; Sheard MA; Zdrazilova-Dubska L
    BMC Cancer; 2019 Jul; 19(1):687. PubMed ID: 31307428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
    Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
    Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
    Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
    Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.
    van Rooijen KL; Shi Q; Goey KKH; Meyers J; Heinemann V; Diaz-Rubio E; Aranda E; Falcone A; Green E; de Gramont A; Sargent DJ; Punt CJA; Koopman M
    Eur J Cancer; 2018 Mar; 91():99-106. PubMed ID: 29353165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995-2004).
    Chen Y; Qiu Z; Kamruzzaman A; Snodgrass T; Scarfe A; Bryant HE
    Support Care Cancer; 2010 Feb; 18(2):217-24. PubMed ID: 19440737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of travel distance on access to treatment and survival in patients with metastatic colorectal cancer prescribed bevacizumab plus chemotherapy.
    Payette E; Sarker S; Chalchal H
    Can J Rural Med; 2017; 22(4):148-152. PubMed ID: 28925914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.